Form 4: Madrigal Pharmaceuticals Chief Commercial Officer Sells Shares to Cover Tax Obligations

Madrigal Pharmaceuticals' Chief Commercial Officer, Carole Huntsman, sold 688 shares of common stock to cover tax obligations related to the vesting of restricted stock units.

Summary

• Carole Huntsman, Chief Commercial Officer of Madrigal Pharmaceuticals, sold 688 shares of common stock on November 21, 2024.
• The sale was executed at a price of $316.92 per share.
• This transaction was to cover tax withholding obligations associated with the vesting of restricted stock units.
• The sale was automatic and not at the discretion of Ms. Huntsman.
• Following the transaction, Ms. Huntsman beneficially owns 10,785 shares of Madrigal Pharmaceuticals common stock.

Sentiment

Score: 5

Explanation: The document describes a routine transaction for tax purposes, which is neither positive nor negative for the company's outlook.

Industry Context

This is a routine transaction for company executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Sales of shares by executives to cover tax obligations are a common practice across the industry.
• The number of shares sold is relatively small compared to the total shares outstanding for Madrigal Pharmaceuticals.
• This type of transaction is not unusual and is generally not seen as a negative signal for the company.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a small sale by an executive for tax purposes.

Key Dates

Keywords

Madrigal Pharmaceuticals, insider trading, Form 4, stock sale, Carole Huntsman, tax obligations, restricted stock units, MDGL, Chief Commercial Officer